Please join Nelson Mullins partners Carrie Hanger and Christopher Hanson for a webinar on Helping Clients Access Medical Innovations while Reducing Risk. During this educational webinar, our professionals will discuss the reasoning behind the differences between clinical research and innovative medical treatment and the risks of ignoring the distinction between clinical research and innovative medical treatment. They will also review humanitarian use devices, emergency use authorization, and emerging therapies.

Carrie Hanger is a seasoned healthcare law, biosciences, and antitrust attorney.  In her healthcare law and biosciences practice, she assists healthcare systems, surgical centers, physician groups, long–term care facilities, hospices, home health providers, and entities engaged in the clinical research across the State of North Carolina and beyond. 

Christopher Hanson is the head of the firm’s FDA Regulatory Compliance & Litigation practice group. He assists clients in tackling their most sophisticated and high-stakes regulatory issues involving medical devices, human and animal drugs, in vitro diagnostics (IVDs), dietary supplements, cosmetics, radiation-emitting electronic products, and clinical laboratories. 

To register, click here.